Raid Aljumaily to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Raid Aljumaily has written about Dose-Response Relationship, Drug.
Connection Strength
0.179
-
Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
Score: 0.139
-
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.
Score: 0.040